compound introduction
本产品仅用作科学研究 Fondaparinux sodium is an antithrombin-dependent factor Xa inhibitor. Fondaparinux sodium is an antithrombin-dependent factor Xa inhibitor.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Fondaparinux sodium
Dangerous GoodsCAS number：114870-03-0 molecular formula：C31H43N3Na10O49S8
overview
Specs
| Chinese alias | Fondaparin sodium, Methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(14)-O-β-D-glucopyranuronosyl-(14)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(14)-O-2-O-sulfo-α-L-idopyranuronosyl-(14)-2-deoxy-2-(sulfoamino)-α-D-glucopyrano | ||
| English alias | FONDAPARINUX SODIUM [JAN] | GSK-576428 | IC-851589 | X0Q6N9USOZ | fondaparinux sodique | Xantidar | decasodium 6-[6-[2-carboxylato-4-hydroxy-6-[4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-5-sulfonatooxy-tetrahydro | ||
| CAS number | 114870-03-0 | molecular formula | C31H43N3Na10O49S8 |
| molecular weight | 1728.08 g/mol | Exact mass | - |
| PSA | 901.000 Ų | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
pictogram：
GHS07
Signal word：
Warning
Hazard Statement：
H332: 吸入有害
Statement of Preventive Measures：
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾 P271: 仅在室外或通风良好的地方使用。 P304+P340: 如误吸入：将人转移到空气新鲜处，保持呼吸舒适体位。 P317: 寻求紧急医疗救助。
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 1 shareMSDS
114870-03-0 | FONDAPARINUX SODIUM FOR ASSAY,UNITED STATES PHARMACOPEIA (USP)REFERENCE STANDARD.pdf
